RegulatoryAlerts Logo
RegulatoryAlerts
InsightsBlogPricingSign InStart Free Trial
All EMA (EU) updates
EMA (EU)
GUIDANCE FINAL
Concept paper on clinical trials in recipients of kidney transplantation
Published: 10/16/2026Detected: 10/16/2026

Summary preview

Introduces an EMA/CHMP concept paper to shape clinical trial considerations specifically for kidney transplant recipients, addressing persistent unmet needs in long-term graft outcomes and the role of immunologic…

Get the full analysis, free

Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.

Create free account
immunology
infectious_disease
pediatrics
clinical
safety
#kidney transplantation
#immunosuppressants
#calcineurin inhibitor nephrotoxicity
#graft rejection
#donor-specific antibodies

Official Source Document
Source Verified

Access the original document directly from EMA.

View Official Document

More from EMA (EU)

  • Mandatory use of ISO/ICH E2B(R3) Individual Case Safety Reporting in the EU: Hands-on training course using the EudraVigilance system10/26/2026
  • Pharmacovigilance Risk Assessment Committee (PRAC): 26 - 29 October 202610/26/2026
  • European platform for regulatory science research meeting: October 202610/22/2026
  • PMS Q&A Clinic on Product User Interface (PUI) and Application Programming Interface (API) – October 202610/22/2026
  • Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - October 202610/21/2026

Get EMA (EU) alerts in your inbox as they are published.

Free plan, 2-minute setup, no credit card required.

RegulatoryAlerts Logo
RegulatoryAlerts

Automated regulatory intelligence monitoring for pharmaceutical and biotech professionals. Track FDA, EMA, and Health Canada updates seamlessly.

Product

  • Insights
  • Updates by Therapeutic Area
  • FDA Updates
  • EMA Updates
  • Pricing
  • Features
  • Request Demo

Resources

  • Integration Guides
  • Regulatory Glossary
  • EMA Timeline
  • Best Practices
  • Therapeutic Areas

Company

  • About Us
  • Blog
  • Contact
  • Security
  • Privacy Policy
  • Terms of Service

    • © 2026 RegulatoryAlerts. All rights reserved.

    Not affiliated with the FDA, EMA, or Health Canada.